Skip to main content
Filing year 2024

TRANSCELERATE BIOPHARMA INC

West Conshohocken, Pennsylvania·EIN 46-0886344·NTEE H99 · Medical Research·501(c)(6)
Total revenue
$38.6M
Total assets
$55.3M
Total expenses
$31.7M
Reported officers
34
Mission

THE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 7 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.

CEO
Above 90th percentile
$1.1M
$1.2M
Base
$786k
Bonus
$276k
Other
Benefits
$29k
COO
Above 90th percentile
$636k
$684k
Base
$442k
Bonus
$140k
Other
Benefits
$40k
Vp, Global Communications & Engagement
Board Vice President
75th to 90th percentile
$506k
$544k
Base
$342k
Bonus
$119k
Other
Benefits
$31k
Vp, Portfolio Management
Board Vice President
75th to 90th percentile
$471k
$506k
Base
$310k
Bonus
$107k
Other
Benefits
$53k
Vp, Portfolio Management
Board Vice President
75th to 90th percentile
$456k
$490k
Base
$300k
Bonus
$89k
Other
Benefits
$59k
Head of Finance & Administration
Highest Compensated Employee
75th to 90th percentile
$445k
$479k
Base
$269k
Bonus
$129k
Other
Benefits
$33k
Exec. Portfolio Director
Highest Compensated Employee
75th to 90th percentile
$430k
$462k
Base
$305k
Bonus
$91k
Other
Benefits
$20k

Teal figures restate each filed amount in 2026 dollars.

Estimated with Philadelphia-Camden-Wilmington, PA-NJ-DE-MD metro-area CPI-U, restating filed pay into April 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 27 unpaid individuals.

Browse compensation in Medical Research

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at TRANSCELERATE BIOPHARMA INC equaled 3% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
3%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Down 56%
from 2023

From $2.5M in 2023 to $1.1M in 2024.

$2.5M
2023
$1.1M
2024
In today's dollarsEst.
Down 58% in real terms$2.8M to $1.2M

Estimated with Philadelphia-Camden-Wilmington, PA-NJ-DE-MD metro-area CPI-U, restating filed pay into April 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Chief Executive Officer pay held roughly steady from 2023 to 2024, while revenue rose 13%.

$1.1M in 2023 to $1.1M in 2024.
  • Chief Operating Officer pay rose 98% from 2023 to 2024.
  • Board Vice President pay fell 18% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

FAQ

Common questions about TRANSCELERATE BIOPHARMA INC

What does the Chief Executive Officer of TRANSCELERATE BIOPHARMA INC earn?

In 2024, the Chief Executive Officer of TRANSCELERATE BIOPHARMA INC received $1,104,805 in total compensation. This pay is in the top 10% for Chief Executive Officer roles among Medical Research organizations nationwide: at least 9 in 10 comparable filings report less. Based on IRS Form 990 data.

How does Chief Executive Officer pay at TRANSCELERATE BIOPHARMA INC compare with similar nonprofits?

Compared with the same role at Medical Research organizations nationwide, the 2024 pay of the Chief Executive Officer at TRANSCELERATE BIOPHARMA INC falls in the top 10%. In 2024, the highest total compensation at TRANSCELERATE BIOPHARMA INC equaled 3% of the organization's total expenses. The median for medical research organizations is 10%.

What are TRANSCELERATE BIOPHARMA INC's revenue and expenses?

In 2024, TRANSCELERATE BIOPHARMA INC reported $38.6M in total revenue and $31.7M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.